Disorders Due to Nicotine Use (ICD-11: 6C4A)

1. Introduction

Disorders due to nicotine use represent one of the most significant public health problems globally, affecting millions of people across all continents. Nicotine, extracted from the plant Nicotiana tabacum, is recognized as the third most consumed psychoactive substance in the world, surpassed only by caffeine and alcohol. Its capacity to generate dependence is extremely potent, making the cessation process particularly challenging for most users.

Appropriate classification of these disorders in ICD-11 through code 6C4A is fundamental for therapeutic planning, epidemiological monitoring, and health resource management. Unlike other psychoactive substances, nicotine presents unique characteristics: its use is more socially accepted in many cultures, it is legally available in most jurisdictions, and its health consequences are predominantly physical and long-term, although associated mental disorders are well documented.

The pattern of nicotine consumption has evolved significantly in recent decades. Although traditional cigarettes remain the most common form of use, electronic cigarettes and vaporization devices have gained increasing popularity, especially among younger populations. This diversification in forms of consumption does not alter the nature of dependence, but presents new diagnostic and therapeutic challenges that health professionals must recognize and address appropriately.

Correct coding is critical not only for statistical purposes, but also to ensure that patients receive appropriate interventions, that health systems can allocate resources adequately, and that researchers can track trends and evaluate the effectiveness of tobacco control policies.

2. Correct ICD-11 Code

Code: 6C4A

Description: Disorders due to use of nicotine

Parent category: Disorders due to substance use

Official definition: Disorders due to use of nicotine are characterized by the pattern and consequences of nicotine use. Nicotine is the active component responsible for dependence on the tobacco plant, Nicotiana tabacum. Nicotine is used mainly through cigarette consumption. Increasingly, it is also used in electronic cigarettes that vaporize nicotine dissolved in a solvent excipient for inhalation (known as "vaping"). Pipe smoking, chewing tobacco, and snuff inhalation are less common forms of use.

This code encompasses a spectrum of conditions related to nicotine use, ranging from isolated episodes of harmful use to severe dependence with multiple failed cessation attempts. The classification recognizes that nicotine is a highly potent addictive component, and that both dependence and withdrawal syndrome are well-characterized clinical phenomena.

Code 6C4A has five subcategories that allow for more detailed diagnostic specification, enabling healthcare professionals to accurately document the specific type of disorder presented by the patient. This specificity is essential for individualized therapeutic planning and for appropriate monitoring of clinical progression.

3. When to Use This Code

The code 6C4A should be used in specific clinical situations where nicotine use results in problematic patterns or adverse consequences. Below are detailed practical scenarios:

Scenario 1: Established dependence with multiple cessation attempts A patient reports smoking 20 cigarettes daily for 15 years, with strong urge to smoke upon waking, inability to remain without smoking for more than two hours without experiencing irritability and anxiety, and at least five previous attempts to quit that failed within two weeks. The patient recognizes that smoking is harming his respiratory health but feels unable to cease use. This is a classic case where 6C4A is appropriate, as there is clear evidence of dependence with functional impairment.

Scenario 2: Electronic cigarette use with development of compulsive pattern A young patient who initiated vaping device use two years ago now uses the device continuously throughout the day, including in environments where it is not permitted, resulting in workplace problems. He experiences strong craving when unable to vape and has progressively increased the nicotine concentration in the liquids used. Although the route of administration is different, the pattern of problematic use justifies the code 6C4A.

Scenario 3: Clinically significant withdrawal syndrome A hospitalized patient undergoing surgical procedure develops, after 24 hours without smoking, intense symptoms including marked irritability, difficulty concentrating, anxiety, increased appetite, and insomnia. These symptoms interfere with postoperative recovery and require specific intervention. Nicotine withdrawal syndrome is a specific disorder within code 6C4A.

Scenario 4: Harmful use without full dependence A patient smokes 10 cigarettes daily for three years, developed chronic cough and recurrent bronchitis directly attributable to smoking. Although he does not meet all criteria for dependence, the pattern of use is causing clear damage to physical health. Harmful use of nicotine is coded within 6C4A.

Scenario 5: Nicotine intoxication A patient without nicotine tolerance experiences, after use of high-concentration tobacco product, intoxication symptoms including nausea, vomiting, dizziness, pallor, diaphoresis, and tachycardia. Although rare in regular users due to developed tolerance, acute nicotine intoxication is recognized within this code.

Scenario 6: Relapse after period of abstinence A patient who had ceased smoking for six months returns to regular use after a stressful event, rapidly reestablishing the previous consumption pattern of 15 cigarettes daily and dependence symptoms. The recurrent nature of nicotine use disorders justifies recoding with 6C4A.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 6C4A is not appropriate, avoiding inadequate coding:

Experimental or occasional use without consequences: A patient reports having smoked occasionally in social contexts, totaling fewer than 10 episodes in the past year, without developing a regular pattern of use, without symptoms of dependence or withdrawal, and without adverse health consequences. This pattern does not constitute a disorder and should not be coded with 6C4A.

Passive exposure to tobacco smoke: Patients exposed to tobacco smoke in the environment (passive smokers) may develop health consequences, but this involuntary exposure is not coded as a disorder due to nicotine use. Respiratory or other consequences should be coded according to the specific condition developed.

Use of prescribed nicotine replacement therapy: Patients using patches, gums, or other nicotine replacement products as part of supervised treatment for smoking cessation should not receive code 6C4A for therapeutic use of the medication, unless they develop dependence on the replacement products themselves, which is rare but possible.

Primary mental disorders exacerbated by nicotine use: A patient with an anxiety disorder who smokes to relieve anxious symptoms should have the anxiety disorder coded primarily. Code 6C4A is added only if there is evidence of nicotine use disorder independent of use, not merely symptomatic use.

Medical conditions caused by tobacco use: Diseases such as chronic obstructive pulmonary disease, lung cancer, or cardiovascular disease caused by tobacco use should be coded with their specific codes. Code 6C4A is additional if the current pattern of use still constitutes an active disorder, but does not replace the coding of medical consequences.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Diagnostic confirmation requires systematic evaluation of multiple dimensions of nicotine use. Begin with a detailed history of use pattern: age of onset, daily amount consumed, forms of nicotine used (cigarettes, electronic cigarettes, chewing tobacco), and total duration of use.

Investigate the presence of dependence symptoms: strong desire or compulsion to use nicotine, difficulty controlling use, withdrawal symptoms when attempting to stop or reduce, need for increasing doses to achieve the same effect (tolerance), neglect of important activities due to use, and persistence of use despite evidence of harmful consequences.

Assess withdrawal symptoms: irritability, frustration or anger, anxiety, difficulty concentrating, increased appetite, restlessness, depressed mood, and insomnia. These symptoms should occur within 24 hours after cessation or reduction of use.

Standardized instruments can assist: the Fagerström Test for Nicotine Dependence is widely used and provides quantitative assessment of dependence severity. Questions about time to first cigarette after waking and difficulty abstaining in prohibited places are particularly revealing.

Physical examination may reveal signs of chronic use: staining on fingers, characteristic odor, dental alterations, and respiratory signs. Complementary tests such as spirometry can document functional consequences.

Step 2: Verify Specifiers

ICD-11 allows additional specification through subcategories of code 6C4A. Determine which subcategory best characterizes the current clinical presentation:

• Single episode of harmful use: pattern of use that caused damage to physical or mental health, but does not meet criteria for dependence
• Pattern of harmful use: recurrent use causing repeated harm
• Nicotine dependence: presence of multiple dependence criteria including impaired control, prioritization of use, and physiological alterations
• Nicotine withdrawal: characteristic syndrome after cessation or reduction
• Mental disorder induced by nicotine: mental condition directly caused by nicotine use

Assess severity considering: frequency and amount of use, degree of functional impairment, presence and intensity of withdrawal symptoms, number of previous cessation attempts, and extent of health consequences.

Document current status: active use, early remission (1-12 months without use), or sustained remission (more than 12 months without use). This information is crucial for longitudinal monitoring.

Step 3: Differentiate from Other Codes

6C40 - Disorders due to use of alcohol: The fundamental difference lies in the substance used. Although alcohol and nicotine may coexist (concurrent use is common), each substance requires separate coding. Alcohol produces intoxication with altered consciousness and motor coordination, while nicotine rarely causes evident intoxication in regular users. Both codes may be applied simultaneously if both disorders are present.

6C41 - Disorders due to use of cannabis: Cannabis produces distinct psychoactive effects including alterations in perception, euphoria, and short-term memory impairment, unlike nicotine which is primarily stimulant. The route of administration may be similar (smoking), but patterns of use and consequences differ substantially. Some users combine tobacco and cannabis, a situation that requires careful evaluation to determine whether there is a disorder related to one or both substances.

6C42 - Disorders due to use of synthetic cannabinoids: These synthetic substances that mimic cannabis effects are completely distinct from nicotine in terms of mechanism of action, clinical effects, and risk profile. Confusion is unlikely in clinical practice, but clear documentation of the substance used is essential.

Step 4: Required Documentation

Checklist of mandatory information for adequate recording:

• Specific type of nicotine product used (conventional cigarettes, electronic cigarettes, chewing tobacco, etc.)
• Approximate daily amount and temporal pattern of use
• Age of onset of regular use
• Total duration of use
• Previous cessation attempts: number, methods used, duration of abstinence achieved
• Dependence symptoms present specifically
• Withdrawal symptoms experienced in previous or current attempts
• Health consequences already identified
• Functional impact: work, relationships, social activities
• Previous treatments for cessation and results
• Current motivation for change
• Relevant medical and psychiatric comorbidities
• Concurrent use of other substances

6. Complete Practical Example

Clinical Case:

A 42-year-old male patient presents for routine consultation reporting concern about his tobacco use. He reports initiating cigarette use at age 16, initially smoking 3-5 cigarettes daily in social contexts. At age 20, after entering the workforce, consumption increased progressively, stabilizing at 20-25 cigarettes daily for approximately 15 years.

The patient reports smoking his first cigarette within 5 minutes of waking up, describing this moment as "essential to start the day." During the work day, he smokes every 1-2 hours, feeling progressively irritable and anxious if he cannot smoke. He has been warned at work for smoking in non-permitted areas. He reports that even when ill with respiratory infections, he continues smoking.

He attempted to quit smoking on six separate occasions in the last 10 years. The longest attempt lasted 3 months, 2 years ago, when he used nicotine gum. He reports that during cessation attempts he experienced intense irritability, difficulty concentrating at work, increased appetite with a 5 kg weight gain, insomnia, and strong craving to smoke. All attempts ended in relapse, usually precipitated by stressful situations.

He developed productive morning cough 5 years ago, which persists daily. He notes dyspnea with moderate exertion that he did not have previously. Physical examination reveals nicotine stains on the index and middle fingers of the right hand, characteristic halitosis, and diffuse rhonchi on lung auscultation. Spirometry performed shows a mild obstructive pattern, consistent with early-stage chronic obstructive pulmonary disease.

The patient expresses genuine concern about his health, especially after a close friend was diagnosed with lung cancer. He manifests desire to quit smoking, but reports feeling "addicted" and fears being unable to tolerate withdrawal symptoms, especially considering his previous experiences.

Step-by-Step Coding:

Criteria Analysis:

The patient presents multiple criteria for nicotine dependence:

• Strong desire/compulsion: cigarette "essential" upon waking, increasing craving during periods without smoking
• Impaired control: smokes even in prohibited areas, continues smoking when ill
• Withdrawal symptoms: irritability, anxiety, difficulty concentrating, insomnia, increased appetite
• Tolerance: progressive increase in consumption over the years
• Prioritization of use: smokes despite workplace warnings
• Persistent use despite consequences: continues smoking despite evident respiratory symptoms
• Multiple failed cessation attempts

The pattern of use is daily, long-standing, and is causing documented consequences to physical health (early-stage chronic obstructive pulmonary disease) and functional impact (workplace problems).

Code Selected: 6C4A.2 - Nicotine dependence

Complete Justification:

The code 6C4A.2 is appropriate because the patient clearly meets the criteria for nicotine dependence as defined in ICD-11. This is not merely harmful use (which would be 6C4A.0 or 6C4A.1), as there is unequivocal evidence of established dependence with manifest neuroadaptive changes evidenced by intense withdrawal symptoms.

The choice of the specific dependence subcategory is justified by the presence of multiple markers of severe dependence: very short time to first cigarette (strong indicator of dependence), inability to control use even in adverse situations, and history of multiple failed cessation attempts with significant withdrawal symptoms.

The current state is active use, not remission, as the patient continues smoking regularly at the time of evaluation.

Complementary Codes:

• [CA22.0](/en/code/CA22.0) - Chronic obstructive pulmonary disease: to document the already-established respiratory consequence
• Z code for history of multiple cessation attempts: if available in the system, to document previous attempts

Multiple coding is appropriate because it recognizes both the substance use disorder and its medical consequences, allowing comprehensive therapeutic planning that addresses both aspects.

7. Related Codes and Differentiation

Within the Same Category:

6C40 - Disorders due to use of alcohol

Use 6C40 when the disorder is specifically related to alcohol consumption, characterized by problematic patterns of alcoholic beverage intake. The main difference is the substance involved and its specific consequences.

Main difference: Alcohol produces acute intoxication with evident alteration of mental state, impaired motor coordination, and behavioral disinhibition. Alcohol withdrawal syndrome can be potentially fatal, including delirium tremens and seizures. Nicotine rarely causes visible intoxication in regular users and its withdrawal, although uncomfortable, is not medically dangerous. Both disorders frequently coexist, requiring dual coding when present.

6C41 - Disorders due to use of cannabis

Use 6C41 when the disorder involves problematic use of cannabis (marijuana), whether natural or in various preparations. Cannabis produces distinct psychoactive effects including alterations in perception, mood, and cognition.

Main difference: Cannabis causes prominent psychoactive effects with alterations in time perception, impairment of short-term memory, and in some cases psychotic symptoms. Nicotine is primarily stimulant without marked psychoactive effects. Although both can be smoked, usage patterns differ: cannabis is typically used episodically for psychoactive effects, while nicotine is used repeatedly throughout the day to maintain blood levels and avoid withdrawal. Nicotine dependence is generally more intense and difficult to treat.

6C42 - Disorders due to use of synthetic cannabinoids

Use 6C42 for disorders related to use of synthetic substances that mimic cannabis effects, frequently marketed as "incense" or "spices" with various commercial names.

Main difference: Synthetic cannabinoids are chemical compounds completely distinct from nicotine, with mechanism of action in the endocannabinoid system, producing potent and unpredictable psychoactive effects. These substances can cause severe intoxication with agitation, psychosis, and even serious medical complications. Nicotine has a well-established and predictable pharmacological profile. Confusion between these categories is unlikely in clinical practice given the marked difference in effects and clinical presentation.

Differential Diagnoses:

Anxiety disorders: Patients with anxiety disorders may use nicotine to relieve anxious symptoms, and nicotine withdrawal can cause anxiety. Differentiation requires assessing whether anxiety preceded nicotine use, whether it persists during prolonged abstinence periods, and whether there are other symptoms of anxiety disorder beyond those related to nicotine use/withdrawal.

Depressive disorder: Smokers have higher rates of depression, and withdrawal can cause depressed mood. Differentiation requires careful temporal evaluation: depressive symptoms that persist beyond 2-4 weeks of abstinence suggest independent depressive disorder. Both conditions can coexist and require separate coding.

Chronic obstructive pulmonary disease and other medical consequences: These are consequences of nicotine use, not substance use disorders. They should be coded separately with their specific codes, additionally to code 6C4A when problematic nicotine use persists.

8. Differences with ICD-10

In ICD-10, tobacco-related disorders were coded primarily with F17 (Mental and behavioral disorders due to use of tobacco), with subdivisions including F17.0 (acute intoxication), F17.1 (harmful use), F17.2 (dependence syndrome), F17.3 (withdrawal syndrome), among others.

ICD-11 introduces significant changes in conceptualization and coding:

Updated terminology: ICD-11 uses "nicotine" instead of "tobacco" or "smoking," recognizing that the addictive substance is nicotine regardless of the route of administration. This change is particularly relevant with the proliferation of electronic cigarettes and other forms of nicotine administration that do not involve tobacco combustion.

Simplified structure: ICD-11 organizes disorders in a more intuitive manner, with clearer categories for harmful use versus dependence, eliminating some subdivisions that were rarely used in clinical practice.

Recognition of new forms of use: ICD-11's definition explicitly mentions electronic cigarettes and vaping, recognizing these emerging forms of nicotine consumption that were not prevalent when ICD-10 was developed.

Refined diagnostic criteria: ICD-11 incorporates decades of research on nicotine dependence, with more precise criteria that better reflect the neurobiology of dependence and facilitate more consistent diagnosis across different professionals and contexts.

Practical impact: Professionals familiar with F17 from ICD-10 will need to adapt to code 6C4A, but the transition is relatively straightforward. The main practical change is the need to specify subcategories with greater precision and the inclusion of non-traditional forms of nicotine use. Electronic health record systems will need to be updated to reflect the new coding structure.

9. Frequently Asked Questions

How is the diagnosis of disorders due to nicotine use made?

The diagnosis is primarily clinical, based on detailed history and evaluation of established criteria. The professional should investigate the pattern of use (quantity, frequency, duration), presence of dependence symptoms (strong desire, impaired control, withdrawal symptoms), and adverse consequences. Standardized instruments such as the Fagerström Test can assist in quantifying severity. There are no specific laboratory tests necessary for diagnosis, although tests such as urinary cotinine may confirm recent use when there is doubt. The evaluation should include physical examination and, when indicated, assessment of medical consequences such as spirometry to evaluate lung function.

Is treatment available in public health systems?

The availability of treatment varies among different health systems, but many public systems recognize smoking as a public health priority and offer some level of support for cessation. Typical treatments include behavioral counseling, which can be offered individually or in groups, and pharmacotherapy including nicotine replacement therapy (patches, gums, lozenges), bupropion, and varenicline. Specific coverage and access to these treatments depend on local health policies. Many systems have implemented cessation support hotlines and free online resources. Professionals should familiarize themselves with the resources available in their specific context to adequately guide patients.

How long does treatment last?

Treatment duration varies significantly among individuals. Typical pharmacotherapy is prescribed for 8-12 weeks, although some patients benefit from more prolonged treatment. Behavioral counseling can range from brief sessions (5-10 minutes) in routine consultations to structured programs of 8-12 weeks with weekly sessions. It is important to recognize that smoking cessation is often a process that requires multiple attempts. Many patients experience relapses and need to restart treatment. Long-term support, even after successful initial cessation, may be important to prevent relapse, especially in the first 6-12 months. There is no defined limit for how long a patient can receive professional support for maintenance of abstinence.

Can this code be used in medical certificates?

Yes, the code 6C4A can be used in medical documentation including certificates when relevant to the clinical situation. However, professionals should consider privacy and stigma issues. In certificates for work leave, it may be more appropriate to code the medical consequences of smoking (such as respiratory disease) rather than the substance use disorder, unless treatment of the specific dependence is the reason for the leave. For detailed medical reports, insurance procedures, or documentation for specialized treatment, complete coding including 6C4A is appropriate and important. Always consider the context and purpose of the documentation, respecting patient confidentiality while providing necessary information.

What is the difference between nicotine dependence and "being a smoker"?

Not every nicotine user has dependence. Some individuals smoke occasionally without developing a compulsive pattern of use or withdrawal symptoms. Dependence is characterized by loss of control over use, strong compulsion to smoke, uncomfortable symptoms when unable to smoke, and continued use despite evident negative consequences. Dependent smokers typically smoke their first cigarette soon after waking, smoke regularly throughout the day, have difficulty in places where smoking is prohibited, and experience multiple failed attempts to quit. Occasional or social smokers who can go days without smoking without significant discomfort generally do not have dependence. The distinction is important because dependence requires more intensive treatment and pharmacological support may be beneficial.

Do electronic cigarettes cause the same type of dependence?

Yes, electronic cigarettes that contain nicotine can cause dependence with characteristics similar to conventional cigarettes, since the addictive substance is the same. Some devices release nicotine even more efficiently than traditional cigarettes, potentially resulting in significant dependence. The same diagnostic criteria apply regardless of the route of nicotine administration. A concerning aspect is that electronic cigarettes have attracted young users who would not smoke conventional cigarettes, creating a new population of nicotine-dependent individuals. The code 6C4A is appropriate for disorders related to nicotine use via electronic cigarettes, and treatment follows similar principles.

Is it possible to have nicotine use disorder along with other substance use disorders?

Yes, it is very common. Smokers have significantly higher rates of problematic use of alcohol, cannabis, and other substances compared to the general population. When multiple substance use disorders are present, each should be coded separately. For example, a patient may have both 6C4A (disorders due to nicotine use) and 6C40 (disorders due to alcohol use). This comorbidity is clinically important because it can complicate treatment: alcohol is a common trigger for relapse in smoking, and vice versa. Integrated treatment that addresses all substances simultaneously is generally more effective than sequential approaches.

After quitting smoking, when is the code no longer necessary?

ICD-11 includes specifiers for remission: early remission (1-12 months without use) and sustained remission (more than 12 months without use). During these periods, the code 6C4A is still relevant, but with the appropriate remission specifier. This recognizes that the risk of relapse remains elevated, especially in the first year. After prolonged sustained remission (several years), the code may no longer be necessary in routine documentation, although the history of prior nicotine dependence may remain relevant for specific contexts. The decision of when to discontinue the code depends on the clinical context and whether the history of dependence remains relevant to current care. There is no rigid cutoff point, and practice varies among professionals and health systems.

---

Conclusion

Disorders due to nicotine use represent a significant public health challenge globally, affecting millions of individuals and causing substantial morbidity and mortality. Appropriate coding through ICD-11 code 6C4A is fundamental for accurate documentation, appropriate therapeutic planning, and effective epidemiological monitoring. Health professionals should be familiar with diagnostic criteria, recognize the diverse forms of presentation including electronic cigarette use, and understand the therapeutic options available. An effective approach requires recognition of the chronic and recurrent nature of nicotine dependence, offering compassionate support through multiple cessation attempts when necessary.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Disorders due to use of nicotine
2. 🔬 PubMed Research on Disorders due to use of nicotine
3. 🌍 WHO Health Topics
4. 📋 NICE Mental Health Guidelines
5. 📊 Clinical Evidence: Disorders due to use of nicotine
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-03